BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback